← Leaderboards
Bruxanne El-Kammash
University Of Chicago
$7,281,050
Attributed
$7,281,050
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.7M · FY2023–25$5M$3.8M$2.5M$1.3M$0
'23
'24
'25
Funding mix
By agency
NIH$7,281,050 · 1
By mechanism
N01$7,281,050 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Shabaana A. Khader$24,868,402
- Qinghua Wang$2,936,120
- Deepak Kaushal$47,591,390
- Anita S. Chong$25,087,826
- Glenn C Randall$9,987,517
Others in their field
Other Rising Stars on “Agonist”
- Sabrina Paganoni · Massachusetts General Hospital$9,298,517
- Suma Babu · Massachusetts General Hospital$9,298,517
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Li Liang · University Of California-Irvine$7,511,446
- Jennifer Lapek · Scripps Institution Of Oceanography$6,359,752
- Andrew Gardiner · Libero Pharma Limited$6,351,015
Research focus
AgonistAdjuvantAntibody Titer MeasurementAntigensChemical StructureAntibodiesContractorContractsEfficacy StudyEmulsionsFerretsFluzoneFormulationChemistryGood Manufacturing ProcessImmune ResponseImmune SystemImmunogenicityImmunologicsImmunologic StimulationImmunomodulatorsInflammationInfluenzaInfluenza A Virus, H1n1 Subtype
Grant awards (3)
DEVELOPMENT OF VACCINES FOR INFLUENZA USING AN IMMUNO-MODULATOR ADJUVANT AND MULTI-PLATFORM APPROACH$1,624,291
N01 · FY2025 · AI · contact PI
DEVELOPMENT OF VACCINES FOR INFLUENZA USING AN IMMUNO-MODULATOR ADJUVANT AND MULTI-PLATFORM APPROACH$3,691,826
N01 · FY2024 · AI · contact PI
DEVELOPMENT OF VACCINES FOR INFLUENZA USING AN IMMUNO-MODULATOR ADJUVANT AND MULTI-PLATFORM APPROACH$1,964,933
N01 · FY2023 · AI · contact PI